Proteoglycan core protein in human urine and its possible role on calcium oxalate urolithiasis

International Journal of Urology

Volumn 6, Issue 11, 1999, Pages 567-571

  Yoshimura, Kazuhiro ^a   Miyake, Osamu ^a   Tsujihata, Masao ^a   Yoshioka, Toshiaki ^a   Yamaguchi, Seiji ^a   Koide, Takuo ^a   Takahara, Shiro ^a   Okuyama, Akihiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Bikunin; Calcium oxalate; Proteoglycan core protein

Indexed keywords

CORE PROTEIN; GLYCOSAMINOGLYCAN; INTER ALPHA TRYPSIN INHIBITOR; LYASE; PROTEOGLYCAN; ULINASTATIN;

ADULT; ARTICLE; CALCIUM OXALATE STONE; CRYSTALLIZATION; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; URINE;

ADULT; AGGRECANS; CALCIUM OXALATE; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; LECTINS, C-TYPE; MALE; PROTEOGLYCANS; URINARY CALCULI; URINE;

EID: 0032744906     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.1999.611107.x     Document Type: Article

References (26)

1. 1 Yoshimura K, Yoshioka T, Miyake O et al. Glycosaminoglycans in crystal-surface binding substances and their role in calcium oxalate crystal growth. Br. J. Urol. 1997; 80: 64-8.
2. 2 Yamaguchi S, Yoshioka T, Utsunomiya M et al. Heparan sulfate in stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol. Res. 1993; 21: 187-92.
3. 3 Boyce W, Garvey FK. The amount and nature of the organic matrix in urinary calculi: A review. J. Urol. 1956; 76: 213-27.
4. 4 Rose GA, Sulaiman S. Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: Quantitative studies. J. Urol. 1982; 127: 177-9.
5. 5 Wiggins RC. Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions. Clin. Chim. Acta 1987; 162: 162-329.
6. 6 Kitamura T, Pak CY. Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro. J. Urol. 1982; 127: 1024-6.
7. 7 Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J. Biol. Chem. 1983; 258: 12594-600.
8. 8 Shiraga H, Min W, Van Dusen WJ et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc. Natl Acad. Sci. USA 1992; 89: 426-30.
9. 9 Stapleton AMF, Ryall RL. Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin. Br. J. Urol. 1995; 75: 712-19.
10. 10 Carey DJ. Syndecans: Multifunctional cell-surface coreceptors. Biochem. J. 1997; 327: 1-16.
11. 11 Fenger M, Wewer U, Albrechtsen R. Basement membrane heparan sulfate proteoglycan from the L2 rat yolk sac carcinoma. FEBS Lett. 1984; 173: 75-9.
12. 12 Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-51.
13. 13 Heukenshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985; 6: 103-12.
14. 14 Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990; 215: 403-10.
15. 15 Finlayson B. Physicochemical aspects of urolithiasis. Bone Mineral 1993; 20: 1-15.
16. 16 Berland Y, Dussol B. New insights into renal stone formation. Curr. Opin. Nephrol. Hypertens. 1994; 3: 417-23.
17. 17 Ryall RL, Harnett RM, Marshall VR. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Clin. Chim. Acta 1981; 112: 349-56.
18. 18 Suzuki K, Mayne K, Doyle IR, Ryall RL. Urinary glycosaminoglycans are selectively induced into calcium oxalate crystals precipitated from whole human urine. Scanning Microsc. 1994; 8: 523-30.
19. 19 Nishio S, Abe Y, Wakatsuki A et al. Matrix glycosaminoglycan in urinary stones. J. Urol. 1985; 134: 503-5.
20. 20 Suzuki K, Ryall RL. The effect of heparan sulfate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine. Br. J. Urol. 1996; 78: 15-21.
21. 21 Boyce WH. Organic matrix of human urinary concretions. Am. J. Med. 1968; 45: 673-83.
22. 22 Hess B, Nakagawa Y, Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am. J. Physiol. 1989; 257: F99.
23. 23 Couchman JR, Woods A. Structure and biology of pericellular proteoglycans. In: Roberts DD, Mecham RP (eds). Cell Surface and Extracellular Glycoconjugates. Academic Press Inc., New York, 1993; 33-82.
24. 24 Balduyck M, Mizon C, Loutfi H, Richet C, Roussel P, Mizon J. The major human urinary trypsin inhibitor is a proteoglycan. Eur. J. Biochem. 1986; 158: 417-22.
25. 25 Atmani F, Lacour B, Strecker G, Parvy P, Drueke T, Daudon M. Molecular characteristics of uronic-acid-rich protein, a strong inhibitor of calcium oxalate crystallization in vitro. Biochem. Biophys. Res. Commun. 1993; 191: 1158-65.
26. 26 Atmani F, Khan SR. Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol. Res. 1995; 23: 95-101.